1. Home
  2. DAKT vs ORIC Comparison

DAKT vs ORIC Comparison

Compare DAKT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$20.32

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$9.05

Market Cap

837.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
ORIC
Founded
1968
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
837.3M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
DAKT
ORIC
Price
$20.32
$9.05
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$19.73
AVG Volume (30 Days)
477.1K
2.3M
Earning Date
03-04-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
19.67
EPS
0.75
N/A
Revenue
$608,932,000.00
N/A
Revenue This Year
$12.94
N/A
Revenue Next Year
$8.32
N/A
P/E Ratio
$25.93
N/A
Revenue Growth
6.89
N/A
52 Week Low
$11.78
$4.19
52 Week High
$28.27
$14.93

Technical Indicators

Market Signals
Indicator
DAKT
ORIC
Relative Strength Index (RSI) 45.41 38.63
Support Level $18.64 $8.78
Resistance Level $20.88 $13.08
Average True Range (ATR) 0.75 1.01
MACD 0.10 -0.35
Stochastic Oscillator 48.70 30.81

Price Performance

Historical Comparison
DAKT
ORIC

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: